Intellia names Jing L. Marantz chief medical officer
Intellia Therapeutics named Jing L. Marantz as executive vice president, chief medical officer, effective Oct. 26, 2026. Marantz will lead translational, development, regulatory, medical affairs functions as Intellia prepares for a first in vivo gene-editing commercialization push. She previously served as chief medica